Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

NCT04625725 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5197

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: AZD7442
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]